Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy
NCT00743639 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2008-08-29
Summary
This study describes a controlled randomized clinical trial to evaluate the efficacy of bone marrow derived stem-cell implants by minithoracotomy in patients with dilated cardiomyopathy and cardiac failure class III or NYHA.
Conditions
- Dilated Cardiomyopathy
Interventions
- PROCEDURE
-
intramyocardial bone marrow stem cells implantation
Control group: the patients will be monitored with regular medical visits. Echocardiography: baseline,3,6,9 months. Cardiac NMR at baseline, 3 and 9 months. Interventional group: Bone-marrow was collected from in the anterior-superior iliac crest and mononuclear stem cells were isolated by centrifugation in the density rate Ficoll-Hypaque 1.077 media. Technique - The approach was through a left mini-thoracotomy. Twenty small injections of cellular suspension were directly made through a 21F butterfly needle(total=5ml), in the anterior, lateral, posterior and apical faces of the LV ((average 9.6±2.6 x 10\[7\] cells). After the procedure, the patients were kept in the p.o. for a minimum period of 24hrs. They were released from the hospital in a period that varied from 5-7 days.
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
collaborator OTHER -
Conselho Nacional de Desenvolvimento Científico e Tecnológico
collaborator OTHER_GOV -
Instituto de Cardiologia do Rio Grande do Sul
lead OTHER
Principal Investigators
-
Renato AK Kalil, MD, PhD · Institute of Cardiology of Rio Grande do Sul / FUC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2006-06-30
- Completion
- 2008-06-30
Countries
- Brazil
Study Locations
More Related Trials
-
Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
NCT02033278 ·Status: TERMINATED ·Phase: PHASE2
-
Progenitor Cell Therapy in Dilative Cardiomyopathy
NCT00284713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure
NCT00462774 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM
NCT03572660 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
NCT01957826 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery
NCT01267331 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy
NCT01753440 ·Status: COMPLETED ·Phase: PHASE2
-
Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure
NCT01693042 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease
NCT02059512 ·Status: COMPLETED ·Phase: NA
-
Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone
NCT00507468 ·Status: COMPLETED ·Phase: PHASE1
-
Combined CABG and Stem-Cell Transplantation for Heart Failure
NCT00418418 ·Status: UNKNOWN ·Phase: PHASE2
-
Cell Therapy in Chronic Ischemic Heart Disease
NCT00362388 ·Status: TERMINATED ·Phase: PHASE3
-
The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction)
NCT01748383 ·Status: UNKNOWN ·Phase: PHASE2
-
Intramyocardial Multiple Precision Injection of Bone Marrow Mononuclear Cells in Myocardial Ischemia
NCT01354678 ·Status: TERMINATED ·Phase: PHASE1
-
Cell Therapy in Myocardial Infarction
NCT00350766 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
NCT00629018 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic Stem Cell Therapy in Heart Failure
NCT03092284 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient
NCT01187654 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
NCT01504594 ·Status: SUSPENDED ·Phase: PHASE1
-
Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure
NCT01502514 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction
NCT01974128 ·Status: WITHDRAWN ·Phase: NA
-
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
NCT00203203 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial Infarction
NCT00437710 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
NCT05566600 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Cell Therapy in Severe Chronic Ischemic Heart Disease
NCT01727063 ·Status: COMPLETED ·Phase: PHASE3